![Immunogenicity of bivalent omicron (BA.1) booster vaccination after different priming regimens in health-care workers in the Netherlands (SWITCH ON): results from the direct boost group of an open-label, multicentre, randomised controlled trial - Immunogenicity of bivalent omicron (BA.1) booster vaccination after different priming regimens in health-care workers in the Netherlands (SWITCH ON): results from the direct boost group of an open-label, multicentre, randomised controlled trial -](https://www.thelancet.com/cms/attachment/72c725a0-6956-4523-b345-3d6fbb9958d3/gr3.jpg)
Immunogenicity of bivalent omicron (BA.1) booster vaccination after different priming regimens in health-care workers in the Netherlands (SWITCH ON): results from the direct boost group of an open-label, multicentre, randomised controlled trial -
Boosters improve diminished protection against Omicron infection after basic COVID-19 vaccination or previous infection | RIVM
![Want to mix and match booster shots? Here's why public health officials aren't letting you — yet | Salon.com Want to mix and match booster shots? Here's why public health officials aren't letting you — yet | Salon.com](https://mediaproxy.salon.com/width/1200/https://media.salon.com/2021/10/covid-19-coronavirus-vaccine-shot-bottle-syringe-1018211.jpg)
Want to mix and match booster shots? Here's why public health officials aren't letting you — yet | Salon.com
![Repeated Covid boosters not viable strategy against new variants, WHO experts warn | Coronavirus | The Guardian Repeated Covid boosters not viable strategy against new variants, WHO experts warn | Coronavirus | The Guardian](https://i.guim.co.uk/img/media/5e6b284eecd4b7774e09293af38755737dd96759/0_121_4250_2550/master/4250.jpg?width=1200&quality=85&auto=format&fit=max&s=79230487f0959cfc33a434ee36400a84)
Repeated Covid boosters not viable strategy against new variants, WHO experts warn | Coronavirus | The Guardian
![Immunogenicity of bivalent omicron (BA.1) booster vaccination after different priming regimens in health-care workers in the Netherlands (SWITCH ON): results from the direct boost group of an open-label, multicentre, randomised controlled trial - Immunogenicity of bivalent omicron (BA.1) booster vaccination after different priming regimens in health-care workers in the Netherlands (SWITCH ON): results from the direct boost group of an open-label, multicentre, randomised controlled trial -](https://www.thelancet.com/cms/attachment/60780324-d5d9-4b6a-a956-6f87101bc7c8/gr2.jpg)
Immunogenicity of bivalent omicron (BA.1) booster vaccination after different priming regimens in health-care workers in the Netherlands (SWITCH ON): results from the direct boost group of an open-label, multicentre, randomised controlled trial -
![Immunogenicity of bivalent omicron (BA.1) booster vaccination after different priming regimens in health-care workers in the Netherlands (SWITCH ON): results from the direct boost group of an open-label, multicentre, randomised controlled trial - Immunogenicity of bivalent omicron (BA.1) booster vaccination after different priming regimens in health-care workers in the Netherlands (SWITCH ON): results from the direct boost group of an open-label, multicentre, randomised controlled trial -](https://www.thelancet.com/cms/attachment/3d186965-5d25-4d1a-a4a3-e4c329ca4400/gr4.jpg)
Immunogenicity of bivalent omicron (BA.1) booster vaccination after different priming regimens in health-care workers in the Netherlands (SWITCH ON): results from the direct boost group of an open-label, multicentre, randomised controlled trial -
![Second booster vaccination against COVID-19 | Advisory report | The Health Council of the Netherlands Second booster vaccination against COVID-19 | Advisory report | The Health Council of the Netherlands](https://www.healthcouncil.nl/binaries/large/content/gallery/gezondheidsraad/content-afbeeldingen/hero-bij-adviezen/vaccinaties/verpleegkundige-vaccineert-man-unsplash_hero.jpg)